论文部分内容阅读
目的:探讨薄芝糖肽治疗老年中晚期恶性肿瘤的临床疗效。方法:选取我院收治的80例老年中晚期恶性肿瘤患者作为研究对象,随机分为研究组和对照组(各40例),对照组患者单纯实施化疗,研究组在此基础上加用薄芝糖肽注射液,比较两组患者的临床疗效。结果:研究组治疗前后的各项指标比较无明显差异(P>0.05),对照组治疗后的PIT、Hb、RBC、WBC水平均明显降低,且与研究组比较有显著性差异(P<0.05)。研究组治疗后的恶心呕吐、食欲减退、神疲乏力发生率均显著低于对照组,P<0.05。研究组的总缓解率为77.50%(31/40),显著高于对照组的65.00%(26/40),P<0.05。结论:对老年中晚期恶性肿瘤化疗患者加用薄芝糖肽,可有效稳定患者的血象,改善全身状况,提高临床疗效,值得推广应用。
Objective: To investigate the clinical effect of baozhi glycopeptide on advanced malignant neoplasm. Methods: Eighty elderly patients with advanced malignant tumors admitted to our hospital were selected as study subjects and randomly divided into study group and control group (40 cases each). Patients in control group were treated with chemotherapy alone. On the basis of this study, Glycopeptide injection, the clinical efficacy of two groups were compared. Results: There was no significant difference between the two groups before and after treatment (P> 0.05). The levels of PIT, Hb, RBC and WBC in the control group were significantly lower than those in the study group (P <0.05) ). The study group after treatment of nausea and vomiting, loss of appetite, the incidence of Shenxian fatigue were significantly lower than the control group, P <0.05. The overall response rate of the study group was 77.50% (31/40), significantly higher than that of the control group (65.00%, 26/40) (P <0.05). Conclusion: It is worth to popularize the application of bosaponin in patients with middle and advanced advanced malignant tumor chemotherapy, which can effectively stabilize the blood picture, improve the general condition and improve the clinical curative effect.